Janssen/ Johnson & Johnson CV-19

Johnson & Johnson

Janssen Pharmaceuticals is a wholly-owned subsidiary of Johnson & Johnson (J&J) and in 2020 they produced a COVID-19 vaccine [Ad26.COV2.S, recombinant] in partnership with Catalent. In June 2020 J&J partnered with the US NIAID/BARDA as part of Operation Warp Speed.…
Moderna COVID-19 vaccine

Moderna

Moderna, based in Cambridge, Massachusett., began it's inception in 2010 following Derek Rossi's breakthrough paper, demonstrating chemically modified mRNA could reprogram adult human fibroblast cells - the prelude to gene therapy. The main investor in the startup was Flagship Pioneering.…
Novavax COVID-19 vaccine

Novavax

Novavax COVID-19 Vaccine by Novavax, Inc. contains SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 saponin-based adjuvant, preservative free, 0.5mL dose. [CDC] The adjuvant which contains saponin extracts from the bark of the Soapbark tree is native to Chile. The adjuvant…